跳至主要内容
临床试验/IRCT20230415057911N1
IRCT20230415057911N1已完成3 期

Comparison of Pregabalin and Cinnarizine on prophylactic treatment of children with migraine

Iran University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 17 years(—)
性别
All

入选标准

  • Consent of parents and children over 13 years to participate in the study
  • Boys and girls aged 6 to 17 years with migraine prophylaxis
  • Migraine diagnosis based on the criteria of the International Headache Society, which includes cases of migraine without aura (5 attacks), migraine with aura (2 attacks), and each attack lasts 1 to 72 hours, and it is pulsating and severe, and accompanied by symptoms With nausea or vomiting, photophobia, phonophobia
  • Not taking pregabalin and cinnarizine in the past

排除标准

  • Drug Intolerance (symptoms such as diarrhea, nausea and vomiting)
  • anaphylaxis
  • severe dizziness
  • excessive sleepiness

研究者

相似试验

Comparison of Pregabalin and Cinnarizine on ... | 临床试验